Original Contributions |
From the Department of Medicine, University of California at San Diego, La Jolla, Calif. R.K.T. is presently at the Department of Medicine/Cardiology, University of Pennsylvania Medical Center, Philadelphia.
Correspondence to Oswald Quehenberger, University of California San Diego, Department of Medicine 0682, 9500 Gilman Dr, La Jolla, CA 92093-0682. E-mail oquehenberger{at}UCSD.edu
AbstractThe subendothelial accumulation of macrophage-derived foam cells is one of the hallmarks of atherosclerosis. The recruitment of monocytes to the intima requires the interaction of locally produced chemokines with specific cell surface receptors, including the receptor (CCR2) for monocyte chemoattractant protein-1 (MCP-1). We have previously reported that monocyte CCR2 gene expression and function are effectively downregulated by proinflammatory cytokines. In this study we identified low density lipoprotein (LDL) as a positive regulator of CCR2 expression. Monocyte CCR2 expression was dramatically increased in hypercholesterolemic patients compared with normocholesterolemic controls. Similarly, incubation of human THP-1 monocytes with LDL induced a rapid increase in CCR2 mRNA and protein. By 24 hours the number of cell surface receptors was doubled, causing a 3-fold increase in the chemotactic response to MCP-1. The increase in CCR2 expression and chemotaxis was promoted by native LDL but not by oxidized LDL. Oxidized LDL rapidly downregulated CCR2 expression, whereas reductively methylated LDL, which does not bind to the LDL receptor, had only modest effects on CCR2 expression. A neutralizing antiLDL receptor antibody prevented the effect of LDL, suggesting that binding and internalization of LDL were essential for CCR2 upregulation. The induction of CCR2 expression appeared to be mediated by LDL-derived cholesterol, because cells treated with free cholesterol also showed increased CCR2 expression. These data suggest that elevated plasma LDL levels in conditions such as hypercholesterolemia enhance monocyte CCR2 expression and chemotactic response and potentially contribute to increased monocyte recruitment to the vessel wall in chronic inflammation and atherogenesis.
Key Words: CCR2 monocyte chemoattractant protein-1 LDL chemotaxis
This article has been cited by other articles:
![]() |
G. Grassia, M. Maddaluno, A. Guglielmotti, G. Mangano, G. Biondi, P. Maffia, and A. Ialenti The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice Cardiovasc Res, December 1, 2009; 84(3): 485 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Qiao, Q. Zhao, C. F. Lee, L. R. Tannock, E. J. Smart, R. G. LeBaron, C. F. Phelix, Y. Rangel, and R. Asmis Thiol Oxidative Stress Induced by Metabolic Disorders Amplifies Macrophage Chemotactic Responses and Accelerates Atherogenesis and Kidney Injury in LDL Receptor-Deficient Mice Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1779 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mohty, P. Pibarot, J.-P. Despres, C. Cote, B. Arsenault, A. Cartier, P. Cosnay, C. Couture, and P. Mathieu Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 187 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hartung, A. Petrov, N. Haider, S. Fujimoto, F. Blankenberg, A. Fujimoto, R. Virmani, F. D. Kolodgie, H. W. Strauss, and J. Narula Radiolabeled Monocyte Chemotactic Protein 1 for the Detection of Inflammation in Experimental Atherosclerosis J. Nucl. Med., November 1, 2007; 48(11): 1816 - 1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Barlic and P. M. Murphy Chemokine regulation of atherosclerosis J. Leukoc. Biol., August 1, 2007; 82(2): 226 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Gleissner, N. Leitinger, and K. Ley Effects of Native and Modified Low-Density Lipoproteins on Monocyte Recruitment in Atherosclerosis Hypertension, August 1, 2007; 50(2): 276 - 283. [Full Text] [PDF] |
||||
![]() |
X. Liu, A. M. Das, J. Seideman, D. Griswold, C. N. Afuh, T. Kobayashi, S. Abe, Q. Fang, M. Hashimoto, H. Kim, et al. The CC Chemokine Ligand 2 (CCL2) Mediates Fibroblast Survival through IL-6 Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 121 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tugizov, R. Herrera, P. Veluppillai, J. Greenspan, D. Greenspan, and J. M. Palefsky Epstein-Barr Virus (EBV)-Infected Monocytes Facilitate Dissemination of EBV within the Oral Mucosal Epithelium J. Virol., June 1, 2007; 81(11): 5484 - 5496. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Boisvert, D. M. Rose, K. A. Johnson, M. E. Fuentes, S. A. Lira, L. K. Curtiss, and R. A. Terkeltaub Up-Regulated Expression of the CXCR2 Ligand KC/GRO-{alpha} in Atherosclerotic Lesions Plays a Central Role in Macrophage Accumulation and Lesion Progression Am. J. Pathol., April 1, 2006; 168(4): 1385 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang and L. M. Wahl Synergistic enhancement of cytokine-induced human monocyte matrix metalloproteinase-1 by C-reactive protein and oxidized LDL through differential regulation of monocyte chemotactic protein-1 and prostaglandin E2 J. Leukoc. Biol., January 1, 2006; 79(1): 105 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fosslien Cardiovascular Complications of Non-Steroidal Anti-Inflammatory Drugs Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 347 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Quehenberger Thematic Review Series: The Immune System and Atherogenesis. Molecular mechanisms regulating monocyte recruitment in atherosclerosis J. Lipid Res., August 1, 2005; 46(8): 1582 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Francone, L. Royer, G. Boucher, M. Haghpassand, A. Freeman, D. Brees, and R. J. Aiello Increased Cholesterol Deposition, Expression of Scavenger Receptors, and Response to Chemotactic Factors in Abca1-Deficient Macrophages Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1198 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Becker Yin and Yang of MCP-1 Circ. Res., April 29, 2005; 96(8): 812 - 814. [Full Text] [PDF] |
||||
![]() |
K. H. Han, J. Ryu, K. H. Hong, J. Ko, Y. K. Pak, J.-B. Kim, S. W. Park, and J. J. Kim HMG-CoA Reductase Inhibition Reduces Monocyte CC Chemokine Receptor 2 Expression and Monocyte Chemoattractant Protein-1-Mediated Monocyte Recruitment In Vivo Circulation, March 22, 2005; 111(11): 1439 - 1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schober, A. Zernecke, E. A. Liehn, P. von Hundelshausen, S. Knarren, W. A. Kuziel, and C. Weber Crucial Role of the CCL2/CCR2 Axis in Neointimal Hyperplasia After Arterial Injury in Hyperlipidemic Mice Involves Early Monocyte Recruitment and CCL2 Presentation on Platelets Circ. Res., November 26, 2004; 95(11): 1125 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Deo, A. Khera, D. K. McGuire, S. A. Murphy, J. de P. Meo Neto, D. A. Morrow, and J. A. de Lemos Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1812 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weber, A. Schober, and A. Zernecke Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 1997 - 2008. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alonso-Villaverde, B. Coll, S. Parra, M. Montero, N. Calvo, M. Tous, J. Joven, and L. Masana Atherosclerosis in Patients Infected With HIV Is Influenced by a Mutant Monocyte Chemoattractant Protein-1 Allele Circulation, October 12, 2004; 110(15): 2204 - 2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Han, K.-H. Hong, J.-H. Park, J. Ko, D.-H. Kang, K.-J. Choi, M.-K. Hong, S.-W. Park, and S.-J. Park C-Reactive Protein Promotes Monocyte Chemoattractant Protein-1--Mediated Chemotaxis Through Upregulating CC Chemokine Receptor 2 Expression in Human Monocytes Circulation, June 1, 2004; 109(21): 2566 - 2571. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishibashi, K.-i. Hiasa, Q. Zhao, S. Inoue, K. Ohtani, S. Kitamoto, M. Tsuchihashi, T. Sugaya, I. F. Charo, S. Kura, et al. Critical Role of Monocyte Chemoattractant Protein-1 Receptor CCR2 on Monocytes in Hypertension-Induced Vascular Inflammation and Remodeling Circ. Res., May 14, 2004; 94(9): 1203 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-S. W. Moller, R. Ovstebo, A.-B. Westvik, G. B. Joo, K.-B. F. Haug, and P. Kierulf Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1{alpha} (MIP-1{alpha}) and the chemokine receptor CCR2 by purified human blood monocytes Innate Immunity, December 1, 2003; 9(6): 349 - 360. [Abstract] [PDF] |
||||
![]() |
K. H. Han, Y. Chen, M. K. Chang, Y. C. Han, J.-H. Park, S. R. Green, A. Boullier, and O. Quehenberger LDL activates signaling pathways leading to an increase in cytosolic free calcium and stimulation of CD11b expression in monocytes J. Lipid Res., July 1, 2003; 44(7): 1332 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Aiello, D. Brees, and O. L. Francone ABCA1-Deficient Mice: Insights Into the Role of Monocyte Lipid Efflux in HDL Formation and Inflammation Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 972 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. de Lemos, D. A. Morrow, M. S. Sabatine, S. A. Murphy, C. M. Gibson, E. M. Antman, C. H. McCabe, C. P. Cannon, and E. Braunwald Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes Circulation, February 11, 2003; 107(5): 690 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Netea, B. J. Kullberg, P. N. M. Demacker, L. E. H. Jacobs, T. J. G. Verver-Jansen, A. Hijmans, L. H. J. van Tits, J. G. J. Hoenderop, P. H. G. M. Willems, J. W. M. Van der Meer, et al. Native LDL potentiate TNF{alpha} and IL-8 production by human mononuclear cells J. Lipid Res., July 1, 2002; 43(7): 1065 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Pinderski, M. P. Fischbein, G. Subbanagounder, M. C. Fishbein, N. Kubo, H. Cheroutre, L. K. Curtiss, J. A. Berliner, and W. A. Boisvert Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor-Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes Circ. Res., May 31, 2002; 90(10): 1064 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Mehta and D. Li Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1429 - 1435. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Aiello, D. Brees, P.-A. Bourassa, L. Royer, S. Lindsey, T. Coskran, M. Haghpassand, and O. L. Francone Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 630 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakajima, Y. Tanaka, T. Nomiyama, T. Ogihara, L. Piao, K. Sakai, T. Onuma, and R. Kawamori Chemokine Receptor Genotype Is Associated With Diabetic Nephropathy in Japanese With Type 2 Diabetes Diabetes, January 1, 2002; 51(1): 238 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wang, Y. L. Siow, and K. O Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-{kappa}B in THP-1 macrophages Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2840 - H2847. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nesbit, H. Schaider, T. H. Miller, and M. Herlyn Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells J. Immunol., June 1, 2001; 166(11): 6483 - 6490. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kito, K. Morishita, and K. Nishida MCP-1 receptor binding affinity is up-regulated by pre-stimulation with MCP-1 in an actin polymerization-dependent manner J. Leukoc. Biol., April 1, 2001; 69(4): 666 - 674. [Abstract] [Full Text] |
||||
![]() |
C. Buechler, H. Ullrich, M. Ritter, M. Porsch-Oezcueruemez, K. J. Lackner, S. Barlage, S. O. Friedrich, G. M. Kostner, and G. Schmitz Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes Blood, February 15, 2001; 97(4): 981 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-W. Park, J.-F. Wang, and J. E. Groopman HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes Blood, January 15, 2001; 97(2): 352 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li and J. L. Mehta Antisense to LOX-1 Inhibits Oxidized LDL-Mediated Upregulation of Monocyte Chemoattractant Protein-1 and Monocyte Adhesion to Human Coronary Artery Endothelial Cells Circulation, June 27, 2000; 101(25): 2889 - 2895. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Murdoch and A. Finn Chemokine receptors and their role in inflammation and infectious diseases Blood, May 15, 2000; 95(10): 3032 - 3043. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Han, S. R. Green, R. K. Tangirala, S. Tanaka, and O. Quehenberger Role of the First Extracellular Loop in the Functional Activation of CCR2. THE FIRST EXTRACELLULAR LOOP CONTAINS DISTINCT DOMAINS NECESSARY FOR BOTH AGONIST BINDING AND TRANSMEMBRANE SIGNALING J. Biol. Chem., November 5, 1999; 274(45): 32055 - 32062. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Han, K. O. Han, S. R. Green, and O. Quehenberger Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia: differential effects of plasma lipoproteins on monocyte function J. Lipid Res., June 1, 1999; 40(6): 1053 - 1063. [Abstract] [Full Text] |
||||
![]() |
R. J. Aiello, D. Brees, P.-A. Bourassa, L. Royer, S. Lindsey, T. Coskran, M. Haghpassand, and O. L. Francone Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 630 - 637. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |